Page last updated: 2024-10-25

damnacanthal and Leukemia, Lymphoblastic, Acute, T Cell

damnacanthal has been researched along with Leukemia, Lymphoblastic, Acute, T Cell in 1 studies

damnacanthal: structure given in first source; isolated from the stem bark and roots of Morinda lucida; a selective inhibitor of p56(lck) tyrosine kinase activity

Research Excerpts

ExcerptRelevanceReference
"Therefore, we report that damnacanthal and nordamnacanthal exhibit anticancer properties by inducing apoptosis and necrosis in CEM-SS cells, and they have potential as a drug for the treatment of T-lymphoblastic leukemia."4.12Ultrastructural and Morphological Effects in T-Lymphoblastic Leukemia CEM-SS Cells Following Treatment with Nordamnacanthal and Damnacanthal from Roots of ( Abdul Rahim, R; Gopalsamy, B; Haji Lajis, N; Latifah, SY; Manaf Ali, A, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Latifah, SY1
Gopalsamy, B1
Abdul Rahim, R1
Manaf Ali, A1
Haji Lajis, N1

Other Studies

1 other study available for damnacanthal and Leukemia, Lymphoblastic, Acute, T Cell

ArticleYear
Ultrastructural and Morphological Effects in T-Lymphoblastic Leukemia CEM-SS Cells Following Treatment with Nordamnacanthal and Damnacanthal from Roots of
    Molecules (Basel, Switzerland), 2022, Jun-28, Volume: 27, Issue:13

    Topics: Aldehydes; Anthraquinones; Apoptosis; Humans; Leukemia, T-Cell; Morinda; Necrosis; Precursor T-Cell

2022